PLoS ONE (Jan 2008)

Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms.

  • Manuel Comabella,
  • David W Craig,
  • Montse Camiña-Tato,
  • Carlos Morcillo,
  • Cristina Lopez,
  • Arcadi Navarro,
  • Jordi Rio,
  • BiomarkerMS Study Group,
  • Xavier Montalban,
  • Roland Martin

DOI
https://doi.org/10.1371/journal.pone.0003490
Journal volume & issue
Vol. 3, no. 10
p. e3490

Abstract

Read online

Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system with an important genetic component and strongest association driven by the HLA genes. We performed a pooling-based genome-wide association study of 500,000 SNPs in order to find new loci associated with the disease. After applying several criteria, 320 SNPs were selected from the microarrays and individually genotyped in a first and independent Spanish Caucasian replication cohort. The 8 most significant SNPs validated in this cohort were also genotyped in a second US Caucasian replication cohort for confirmation. The most significant association was obtained for SNP rs3129934, which neighbors the HLA-DRB/DQA loci and validates our pooling-based strategy. The second strongest association signal was found for SNP rs1327328, which resides in an unannotated region of chromosome 13 but is in linkage disequilibrium with nearby functional elements that may play important roles in disease susceptibility. This region of chromosome 13 has not been previously identified in MS linkage genome screens and represents a novel risk locus for the disease.